{
  "url": "https://openlegislation.uk/medicines-applications-for-manufacturers-and-wholesale-dealers-licences-regulations-1971/schedule-1/paragraph-5",
  "json_url": "https://openlegislation.uk/medicines-applications-for-manufacturers-and-wholesale-dealers-licences-regulations-1971/schedule-1/paragraph-5.json",
  "legislation": "uksi/1971/974",
  "legislation_title": "The Medicines (Applications for Manufacturer's and Wholesale Dealer's Licences) Regulations 1971",
  "legislation_url": "https://openlegislation.uk/medicines-applications-for-manufacturers-and-wholesale-dealers-licences-regulations-1971",
  "path": "schedule/1/paragraph/5",
  "kind": "paragraph",
  "number": "5",
  "heading": null,
  "text": "(1) The address of each of the premises where the manufacturing or assembling operations to which the application relates, or both operations, including any testing associated with manufacture or assembly, are or are to be carried out.\n(2) The address of each of the premises if different from those referred to in the preceding subparagraph—\n(a) on which are to be kept any living animals, or\n(b) on which are to be kept or from which are to be obtained any materials of animal origin,\nfrom which, in either case, are to be derived any substance or substances used in the production of the medicinal product whether human or veterinary to which the application relates.\n(3) The address of each of the premises where the proposed licensee proposes to store medicinal products or from which he proposes to distribute them.\n(4) A statement indicating the facilities and equipment available at each of the premises for storing the medicinal products on, and distributing them from or between, such premises.\n(5) A separate statement in respect of each of the premises, of the manufacturing or assembling operations capable of being carried out at those premises with their existing facilities. Each statement shall specify the classes of medicinal products to which the operations are relevant.\n(6) A separate statement in respect of each of the premises, of equipment available at those premises for carrying out each stage of the manufacturing or assembling operations described in subparagraph (5) of this paragraph.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [
    {
      "type": "added",
      "affecting": "uksi/2010/1882",
      "affecting_title": "The Medicines for Human Use (Advanced Therapy Medicinal Products and Miscellaneous Amendments) Regulations 2010"
    },
    {
      "type": "subst",
      "affecting": "uksi/2005/2789",
      "affecting_title": "The Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005"
    },
    {
      "type": "rev in pt",
      "affecting": "uksi/2005/2789",
      "affecting_title": "The Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005"
    },
    {
      "type": "am",
      "affecting": "uksi/2005/2789",
      "affecting_title": "The Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/1971/974/schedule/1/paragraph/5",
    "retrieved_at": "2026-10-29T22:44:19.923041+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}